{"text": ["AbbVie", "Submits", "Anti-Inflammatory", "Drug", "Rinvoq", "for", "FDA,", "Europe", "Approval", "for", "Atopic", "Dermatitis"], "created_at": "2020-10-19 22:55:26"}
{"text": ["Analyst", "Report:", "AbbVie", "Inc."], "created_at": "2020-10-19 22:37:18"}
{"text": ["AbbVie", "Submits", "Regulatory", "Applications", "to", "FDA", "and", "EMA", "for", "RINVOQ\u2122", "(upadacitinib)", "in", "Atopic", "Dermatitis"], "created_at": "2020-10-19 14:06:00"}
{"text": ["Roche", "(RHHBY),", "AbbVie's", "Leukemia", "Drug", "Venclexta", "Get", "Full", "FDA", "Nod"], "created_at": "2020-10-19 13:27:01"}
{"text": ["AbbVie", "Announces", "Commencement", "of", "Registered", "Exchange", "Offers"], "created_at": "2020-10-19 12:56:00"}
